Method for predicting the responsiveness a patient to a treatment with an anti-CD20 antibody
US9879325B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 27, 2015 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Feb 27, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for predicting the responsiveness of a patient to a treatment with an anti-CD20 antibody, said method comprising measuring the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in B cells obtained from said patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.